[go: up one dir, main page]

FR2486400B1 - Medicaments a base de levures ou de leurs extraits insolubles - Google Patents

Medicaments a base de levures ou de leurs extraits insolubles

Info

Publication number
FR2486400B1
FR2486400B1 FR8015242A FR8015242A FR2486400B1 FR 2486400 B1 FR2486400 B1 FR 2486400B1 FR 8015242 A FR8015242 A FR 8015242A FR 8015242 A FR8015242 A FR 8015242A FR 2486400 B1 FR2486400 B1 FR 2486400B1
Authority
FR
France
Prior art keywords
yeast
products based
medicinal products
insoluble extracts
insoluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8015242A
Other languages
English (en)
Other versions
FR2486400A1 (fr
Inventor
Jacqueline Olga Massot
Jacques Noel Astoin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Univablot
Original Assignee
Univablot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univablot filed Critical Univablot
Priority to FR8015242A priority Critical patent/FR2486400B1/fr
Publication of FR2486400A1 publication Critical patent/FR2486400A1/fr
Application granted granted Critical
Publication of FR2486400B1 publication Critical patent/FR2486400B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8015242A 1980-07-09 1980-07-09 Medicaments a base de levures ou de leurs extraits insolubles Expired FR2486400B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8015242A FR2486400B1 (fr) 1980-07-09 1980-07-09 Medicaments a base de levures ou de leurs extraits insolubles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8015242A FR2486400B1 (fr) 1980-07-09 1980-07-09 Medicaments a base de levures ou de leurs extraits insolubles

Publications (2)

Publication Number Publication Date
FR2486400A1 FR2486400A1 (fr) 1982-01-15
FR2486400B1 true FR2486400B1 (fr) 1986-05-30

Family

ID=9244014

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8015242A Expired FR2486400B1 (fr) 1980-07-09 1980-07-09 Medicaments a base de levures ou de leurs extraits insolubles

Country Status (1)

Country Link
FR (1) FR2486400B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10117915B2 (en) 2009-09-14 2018-11-06 The Regents Of The University Of Colorado, A Body Corporate Modulation of yeast-based immunotherapy products and responses

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58212779A (ja) * 1982-06-04 1983-12-10 Sapporo Breweries Ltd 酵母
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
FR2742440B1 (fr) * 1995-12-14 1999-02-05 Serobiologiques Lab Sa Procede de production de glycogene ou d'un extrait riche en glycogene a partir de cellules de levure et composition cosmetique les contenant
AU2002225681A1 (en) * 2000-11-15 2002-05-27 Globe Immune, Inc. Yeast-dentritic cell vaccines and uses thereof
US20060100171A1 (en) * 2002-09-09 2006-05-11 Ekhart Peter F Branched alpha-glucans for weight management
EP2630969B1 (fr) 2002-12-16 2018-04-11 GlobeImmune, Inc. Vaccins à base de levure pour immunotherapie
US7439042B2 (en) 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
US8343502B2 (en) 2002-12-16 2013-01-01 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
CN102614510A (zh) 2004-10-18 2012-08-01 全球免疫股份有限公司 基于酵母的对慢性丙型肝炎感染的治疗
US20070172503A1 (en) 2005-12-13 2007-07-26 Mycologics,Inc. Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
JP2009531068A (ja) 2006-03-27 2009-09-03 グローブイミューン，インコーポレイテッド Ｒａｓ変異並びにこれに関連する組成物及び方法
PL2121013T3 (pl) 2007-02-02 2015-05-29 Globeimmune Inc Sposoby wytwarzania szczepionek na bazie drożdży
BRPI0809247A2 (pt) 2007-03-19 2014-09-09 Globeimmune Inc Composições e métodos para a ablação do escape mutacional de terapias marcadas para câncer.
WO2010033841A1 (fr) 2008-09-19 2010-03-25 Globeimmune, Inc. Immunothérapie pour infection chronique par le virus de l'hépatite c
KR102019728B1 (ko) 2009-04-17 2019-09-09 글로브이뮨 암에 대한 병용 면역요법 조성물 및 방법
EP2651439B1 (fr) 2010-12-17 2018-09-19 Globeimmune, Inc. Compositions et procédés pour le traitement ou la prévention d'une infection par l'adénovirus 36 humain
CA2827150C (fr) 2011-02-12 2018-09-11 Globeimmune, Inc. Therapeutique a base de levure pour infection chronique par l'hepatite b
WO2012125998A1 (fr) 2011-03-17 2012-09-20 Globeimmune, Inc. Compositions immunothérapeutiques de levure-brachyury
EA030381B1 (ru) 2011-06-14 2018-07-31 Глоубиммьюн, Инк. Иммунотерапевтическая композиция, ее применения и способы лечения или профилактики инфекции, вызванной вирусом гепатита дельта
KR102049928B1 (ko) 2011-08-17 2019-11-28 글로브이뮨 효모-muc1 면역요법 조성물 및 그 용도
SG11201408652SA (en) 2012-06-26 2015-01-29 Biodesix Inc Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies
EP2976100B1 (fr) 2013-03-19 2020-07-01 Globeimmune, Inc. Immunothérapie à base de levure pour un chordome
TWI728239B (zh) 2013-03-26 2021-05-21 美商環球免疫公司 治療或預防人類免疫缺乏病毒感染之組合物及方法
US10226522B2 (en) 2013-08-30 2019-03-12 Globeimmune, Inc. Compositions and methods for the treatment or prevention of tuberculosis
CA2948803A1 (fr) 2014-04-11 2015-10-15 Globeimmune, Inc. Immunotherapie a base de levure et sensibilite a l'interferon de type 1
TWI748957B (zh) 2015-08-03 2021-12-11 美商環球免疫公司 經修飾之酵母-短尾畸型（Ｂｒａｃｈｙｕｒｙ）免疫治療組合物
EP3793576A4 (fr) 2018-05-15 2022-04-06 Globeimmune, Inc. Lysats de levure recombinante pour induire des réponses immunitaires cellulaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB300039A (en) * 1927-12-24 1928-11-08 Matro G M B H Method of manufacturing dry yeasts for medical and pharmaceutical purposes
FR1538957A (fr) * 1964-02-17 1968-09-13 Robert & Carriere Lab Perfectionnement à la culture des levures
US3954979A (en) * 1972-11-24 1976-05-04 Ceres Products Company, Inc. Process for preparing stabilized yeast and compositions and tableting composition and method
FR2228470A1 (en) * 1973-05-09 1974-12-06 Degemont Marguerite Therapeutic compsn. contg. vitamin A, sulphur and live yeast - for treatment of disorders of the ear, nose and throat
DE2452303A1 (de) * 1974-11-05 1976-05-13 Bayer Ag Extraktionsprodukte aus hefezellwandbestandteile enthaltendem material, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10117915B2 (en) 2009-09-14 2018-11-06 The Regents Of The University Of Colorado, A Body Corporate Modulation of yeast-based immunotherapy products and responses

Also Published As

Publication number Publication date
FR2486400A1 (fr) 1982-01-15

Similar Documents

Publication Publication Date Title
FR2486400B1 (fr) Medicaments a base de levures ou de leurs extraits insolubles
DE3679115D1 (de) Tablettenverpackung.
FR2482456B1 (fr) Composition en gel, anti-inflammatoire et analgesique, a base de ketoprofene et/ou de flurbiprofene
DK153787A (da) Laegemidler med langsom frigivelse
PT73686A (pt) Pharmaceutical formulation
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
FI863077A0 (fi) Farmaceutisk dosenhet.
FR2555049B1 (fr) Medicaments a base de carboxymethoxy-7 furo-(3,4-c)-pyridine
DK154186C (da) Lamineret, let oploeseligt farmaceutisk enhedsdosisformlegeme
BR1100678A (pt) Tetrahidro-benzoatiazol, sua preparação e seu uso como produto intermediário ou como medicamento
BE883495A (fr) Medicament hypolipemiqude a base de carnitine
FI862590A0 (fi) Farmaceutiska produkter.
FI850455L (fi) Farmaceutiska produkter.
FR2338951A1 (fr) Nouveaux esters-17 a d'hydroxy-17 a-progestatifs utiles comme medicaments et leurs procedes de preparation
BE854171A (fr) 2-imino-thiazolidines et thiazolines utiles comme medicaments
FR2313075A1 (fr) Medicament a base de l-pyroglutamyl-l-histidyl-l-prolinamide ou ses sels
FI862371A (fi) Farmaceutisk tablett.
FI810934L (fi) Farmaceutiska produkter
LU81237A1 (fr) Medicament a base de derives de la thienopyridone ou de la furopyridone
BE875669A (fr) Medicaments a base de derives de l'acide anthranilique
FI803846L (fi) Farmaceutiska produkter
BE865369A (fr) Medicament a base d'extrait de physarym
DE3781045D1 (de) Antirheumatisches arzneimittel.
IT8520591A0 (it) Formulazione farmaceutica.
NL930050I2 (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse